Mona Arab‐Alameddine

411 total citations
8 papers, 294 citations indexed

About

Mona Arab‐Alameddine is a scholar working on Infectious Diseases, Pediatrics, Perinatology and Child Health and Pharmacology. According to data from OpenAlex, Mona Arab‐Alameddine has authored 8 papers receiving a total of 294 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 4 papers in Pediatrics, Perinatology and Child Health and 2 papers in Pharmacology. Recurrent topics in Mona Arab‐Alameddine's work include HIV/AIDS drug development and treatment (7 papers), Pharmacological Effects and Toxicity Studies (4 papers) and HIV Research and Treatment (2 papers). Mona Arab‐Alameddine is often cited by papers focused on HIV/AIDS drug development and treatment (7 papers), Pharmacological Effects and Toxicity Studies (4 papers) and HIV Research and Treatment (2 papers). Mona Arab‐Alameddine collaborates with scholars based in Switzerland, United Kingdom and China. Mona Arab‐Alameddine's co-authors include Amalio Telenti, Laurent A. Décosterd, Chantal Csajka, Margalida Rotger, Julia di Iulio, Rubin Lubomirov, Matthias Cavassini, Chin B. Eap, Aurélie Fayet and Thierry Buclin and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Clinical Pharmacology & Therapeutics and Expert Opinion on Drug Metabolism & Toxicology.

In The Last Decade

Mona Arab‐Alameddine

8 papers receiving 290 citations

Peers

Mona Arab‐Alameddine
Megan Neary United Kingdom
Alina S Bergshoeff Netherlands
Elgin Green United States
Justin Koteff United Kingdom
Rand R. Rhodes United States
Nardin Rezk United States
Griet Boogaerts United States
Mona Arab‐Alameddine
Citations per year, relative to Mona Arab‐Alameddine Mona Arab‐Alameddine (= 1×) peers L. Trentini

Countries citing papers authored by Mona Arab‐Alameddine

Since Specialization
Citations

This map shows the geographic impact of Mona Arab‐Alameddine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mona Arab‐Alameddine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mona Arab‐Alameddine more than expected).

Fields of papers citing papers by Mona Arab‐Alameddine

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mona Arab‐Alameddine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mona Arab‐Alameddine. The network helps show where Mona Arab‐Alameddine may publish in the future.

Co-authorship network of co-authors of Mona Arab‐Alameddine

This figure shows the co-authorship network connecting the top 25 collaborators of Mona Arab‐Alameddine. A scholar is included among the top collaborators of Mona Arab‐Alameddine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mona Arab‐Alameddine. Mona Arab‐Alameddine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
2.
Guidi, Monia, Mona Arab‐Alameddine, Margalida Rotger, et al.. (2012). Dosage Optimization of Treatments Using Population Pharmacokinetic Modeling and Simulation. CHIMIA International Journal for Chemistry. 66(5). 291–291. 7 indexed citations
3.
Lubomirov, Rubin, Mona Arab‐Alameddine, Margalida Rotger, et al.. (2012). Pharmacogenetics-based population pharmacokinetic analysis of etravirine in HIV-1 infected individuals. Pharmacogenetics and Genomics. 23(1). 9–18. 22 indexed citations
4.
Arab‐Alameddine, Mona, Aurélie Fayet-Mello, Rubin Lubomirov, et al.. (2012). Population Pharmacokinetic Analysis and Pharmacogenetics of Raltegravir in HIV-Positive and Healthy Individuals. Antimicrobial Agents and Chemotherapy. 56(6). 2959–2966. 31 indexed citations
5.
Arab‐Alameddine, Mona, Thierry Buclin, Monia Guidi, et al.. (2012). Pragmatic approach for interpreting antiretroviral drug concentrations based on a systematic review of population pharmacokinetic studies. SERVAL (Université de Lausanne). 21. 1 indexed citations
6.
Arab‐Alameddine, Mona, Laurent A. Décosterd, Thierry Buclin, Amalio Telenti, & Chantal Csajka. (2011). Antiretroviral drug toxicity in relation to pharmacokinetics, metabolic profile and pharmacogenetics. Expert Opinion on Drug Metabolism & Toxicology. 7(5). 609–622. 9 indexed citations
7.
Iulio, Julia di, Aurélie Fayet, Mona Arab‐Alameddine, et al.. (2009). In vivo analysis of efavirenz metabolism in individuals with impaired CYP2A6 function. Pharmacogenetics and Genomics. 19(4). 300–309. 120 indexed citations
8.
Arab‐Alameddine, Mona, Julia di Iulio, Thierry Buclin, et al.. (2009). Pharmacogenetics-Based Population Pharmacokinetic Analysis of Efavirenz in HIV-1-Infected Individuals. Clinical Pharmacology & Therapeutics. 85(5). 485–494. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026